Vanessa Carle - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Secretary
Signature
/Vanessa Carle/
Issuer symbol
LEXX
Transactions as of
29 Jul 2025
Net transactions value
+$682
Form type
4
Filing time
30 Jul 2025, 11:23:09 UTC
Previous filing
16 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carle Vanessa Secretary 100 - 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA /Vanessa Carle/ 30 Jul 2025 0001855763

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $682 +750 $0.9100 750 29 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 12,500 29 Jul 2025 Common Shares 12,500 $3.00 Direct
holding LEXX Stock Options 17,500 29 Jul 2025 Common Shares 5,000 $3.00 Direct
holding LEXX Stock Options 27,500 29 Jul 2025 Common Shares 10,000 $3.00 Direct
holding LEXX Stock Options 40,000 29 Jul 2025 Common Shares 12,500 $2.91 Direct
holding LEXX Stock Options 50,000 29 Jul 2025 Common Shares 10,000 $1.15 Direct
holding LEXX Stock Options 60,000 29 Jul 2025 Common Shares 10,000 $2.36 Direct
holding LEXX Stock Options 75,000 29 Jul 2025 Common Shares 15,000 $1.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.